Biora Therapeutics (NASDAQ:BIOR) is set to give its latest quarterly earnings report on Thursday, 2023-03-30. Here’s what investors need to know before the announcement.
Analysts estimate that Biora Therapeutics will report an earnings per share (EPS) of $-1.44.
Biora Therapeutics bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Historical Earnings Performance
Last quarter the company missed EPS by $0.25, which was followed by a 4.98% drop in the share price the next day.
Stock Performance
Shares of Biora Therapeutics were trading at $2.58 as of March 28. Over the last 52-week period, shares are down 85.97%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
To track all earnings releases for Biora Therapeutics visit their earnings calendar on our site.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
